Casdin Capital’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-221,162
| Closed | -$21.8M | – | 55 |
|
|
2021
Q1 | $21.8M | Sell |
221,162
-143,838
| -39% | -$14.2M | 0.65% | 32 |
|
|
2020
Q4 | $39.6M | Buy |
365,000
+90,000
| +33% | +$9.76M | 1.17% | 23 |
|
|
2020
Q3 | $28.3M | Buy |
275,000
+88,500
| +47% | +$9.12M | 1.27% | 22 |
|
|
2020
Q2 | $38.9M | Buy |
186,500
+74,000
| +66% | +$15.5M | 2.3% | 15 |
|
|
2020
Q1 | $11M | Buy |
+112,500
| New | +$11M | 1.17% | 26 |
|
|
2018
Q2 | – | Sell |
-30,000
| Closed | -$1.74M | – | 33 |
|
|
2018
Q1 | $1.74M | Buy |
+30,000
| New | +$1.74M | 0.31% | 29 |
|
|
2017
Q2 | – | Sell |
-42,000
| Closed | -$1.13M | – | 32 |
|
|
2017
Q1 | $1.13M | Buy |
+42,000
| New | +$1.13M | 0.67% | 28 |
|